Milos G.
- Country
- Slovakia
- Department
- Gastroenterology
Research Overview
- A randomized, double-blind, placebo controlled, dose finding study to assess the efficacy and safety of SAR443122 in adult patients with moderate to severe ulcerative colitis
- A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderately to Severely Active Ulcerative Colitis
- Phase 3 Randomized Double‑Blind Study Evaluating Efficacy and Safety of JNJ‑78934804 Combination Therapy versus Guselkumab in Moderately to Severely Active Crohn’s Disease
Data & Insights
Has run more than one trial at 353 of 569 partner sites.
Specializations
Inflammatory Bowel Disease Management
This investigator specializes in treating complex gastrointestinal conditions, with particular focus on inflammatory bowel diseases. Their expertise encompasses both ulcerative colitis and Crohn's disease management.
- Moderate to Severe Disease States
- Therapeutic Response Assessment
- Disease Activity Monitoring
Their work extends to evaluating novel therapeutic approaches for patients with treatment-resistant conditions.
Therapeutic Innovation
The investigator focuses on advancing treatment options through evaluation of targeted therapies and biological agents for gastrointestinal disorders.
- Novel Drug Development
- Treatment Response Evaluation
- Long-term Efficacy Assessment
Their research encompasses both induction and maintenance therapy protocols for inflammatory conditions.
Clinical Outcomes
The investigator's work centers on measuring therapeutic outcomes in gastrointestinal disorders, with particular attention to endoscopic improvement and clinical remission.
- Symptomatic Relief Assessment
- Remission Maintenance
- Quality of Life Improvements
Their research includes evaluation of bowel urgency and other disease-specific symptoms.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.